FBIO Fortress Biotech Inc

Price (delayed)

$3.5

Market cap

$340.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.37

Enterprise value

$136.42M

Highlights
The company's equity has surged by 184% YoY and by 6% QoQ
FBIO's quick ratio has soared by 76% YoY and by 9% QoQ
FBIO's revenue is down by 2.9% since the previous quarter but it is up by 2.8% year-on-year
FBIO's gross margin is down by 6% YoY
The gross profit has declined by 4.6% since the previous quarter and by 3.4% year-on-year

Key stats

What are the main financial stats of FBIO
Market
Shares outstanding
97.32M
Market cap
$340.62M
Enterprise value
$136.42M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.14
Price to sales (P/S)
6.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.08
Earnings
Revenue
$44.27M
EBIT
-$28.45M
EBITDA
-$24.46M
Free cash flow
-$86.54M
Per share
EPS
-$1.37
Free cash flow per share
-$1.07
Book value per share
$1.12
Revenue per share
$0.55
TBVPS
$4.66
Balance sheet
Total assets
$391.04M
Total liabilities
$146.82M
Debt
$87.35M
Equity
$105.9M
Working capital
$264.17M
Liquidity
Debt to equity
0.82
Current ratio
5.91
Quick ratio
5.79
Net debt/EBITDA
8.35
Margins
EBITDA margin
-55.3%
Gross margin
66.8%
Net margin
-97.1%
Operating margin
-232.1%
Efficiency
Return on assets
-13.4%
Return on equity
-47.3%
Return on invested capital
-24.8%
Return on capital employed
-8.4%
Return on sales
-64.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
-2.78%
1 week
-22.05%
1 month
-6.67%
1 year
25.45%
YTD
10.41%
QTD
-0.85%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$44.27M
Gross profit
$29.58M
Operating income
-$102.76M
Net income
-$42.98M
Gross margin
66.8%
Net margin
-97.1%
The net margin has increased by 22% YoY and by 4.8% QoQ
FBIO's net income is up by 20% YoY and by 8% QoQ
FBIO's operating margin is down by 12% since the previous quarter
FBIO's operating income is down by 9% from the previous quarter and by 3% YoY

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
N/A
P/B
3.14
P/S
6.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.08
Fortress Biotech's EPS has increased by 28% YoY and by 4.2% QoQ
The company's equity has surged by 184% YoY and by 6% QoQ
The P/B is 38% less than the 5-year quarterly average of 5.1 and 8% less than the last 4 quarters average of 3.4
The P/S is 12% above the last 4 quarters average of 5.7 but 11% below the 5-year quarterly average of 7.2
FBIO's revenue is down by 2.9% since the previous quarter but it is up by 2.8% year-on-year

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity has surged by 73% YoY and by 25% QoQ
The ROA has grown by 44% year-on-year and by 19% since the previous quarter
Fortress Biotech's return on sales has increased by 33% YoY and by 6% QoQ
FBIO's return on invested capital is up by 21% year-on-year and by 6% since the previous quarter

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets is 166% more than the total liabilities
Fortress Biotech's current ratio has soared by 93% YoY and by 8% from the previous quarter
FBIO's quick ratio has soared by 76% YoY and by 9% QoQ
The debt is 18% lower than the equity
The company's equity has surged by 184% YoY and by 6% QoQ
The debt to equity has dropped by 72% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.